Responses
Poster Presentations
SLE, Sjögren's and APS - treatment
SAT0220 Effects of type I interferon inhibition on blood leukocyte subsets in patients treated in a phase IIB clinical study of anifrolumab in systemic lupus erythematosus (SLE)
Compose a Response to This Article
Other responses
No responses have been published for this article.